MX2022011542A - Soluciones antimicrobianas y procedimientos de uso de las mismas en el tratamiento o la prevencion de infecciones. - Google Patents

Soluciones antimicrobianas y procedimientos de uso de las mismas en el tratamiento o la prevencion de infecciones.

Info

Publication number
MX2022011542A
MX2022011542A MX2022011542A MX2022011542A MX2022011542A MX 2022011542 A MX2022011542 A MX 2022011542A MX 2022011542 A MX2022011542 A MX 2022011542A MX 2022011542 A MX2022011542 A MX 2022011542A MX 2022011542 A MX2022011542 A MX 2022011542A
Authority
MX
Mexico
Prior art keywords
methods
respiratory tract
upper respiratory
infections
prevention
Prior art date
Application number
MX2022011542A
Other languages
English (en)
Inventor
Gudmundur Fertram Sigurjonsson
Dora Hlin Gisladottir
Original Assignee
Kerecis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerecis Ag filed Critical Kerecis Ag
Publication of MX2022011542A publication Critical patent/MX2022011542A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Las composiciones antimicrobianas incluyen una cantidad efectiva para uso terapéutico de aceite de neem, extracto de la planta Hypericum spp., ácidos grasos poliinsaturados (PUFA), carrageninas y/o clorhexidina; y (de manera opcional) en combinación con uno o más vehículos, aditivos y/o diluyentes aceptables para uso farmacéutico. Las composiciones antimicrobianas son eficaces para el tratamiento o la prevención de infecciones del tracto respiratorio superior, preferentemente infecciones del tracto respiratorio superior provocadas por coronavirus humanos y se incluyen dentro de los procedimientos para el tratamiento o la prevención de la infección del tracto respiratorio superior de seres humanos por un patógeno microbiano.
MX2022011542A 2020-03-23 2021-03-23 Soluciones antimicrobianas y procedimientos de uso de las mismas en el tratamiento o la prevencion de infecciones. MX2022011542A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US202062993356P 2020-03-23 2020-03-23
US202062993360P 2020-03-23 2020-03-23
US202062993201P 2020-03-23 2020-03-23
US202063003887P 2020-04-01 2020-04-01
US202063004467P 2020-04-02 2020-04-02
US202063040807P 2020-06-18 2020-06-18
US202063091177P 2020-10-13 2020-10-13
PCT/IB2021/052408 WO2021191800A1 (en) 2020-03-23 2021-03-23 Antimicrobial solutions and methods of using the same in the treatment or prevention of infections

Publications (1)

Publication Number Publication Date
MX2022011542A true MX2022011542A (es) 2022-11-07

Family

ID=75252593

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011542A MX2022011542A (es) 2020-03-23 2021-03-23 Soluciones antimicrobianas y procedimientos de uso de las mismas en el tratamiento o la prevencion de infecciones.

Country Status (14)

Country Link
US (1) US20210290533A1 (es)
EP (1) EP4125982A1 (es)
JP (1) JP2023519359A (es)
KR (1) KR20220157997A (es)
CN (1) CN115484969A (es)
AU (1) AU2021240472A1 (es)
BR (1) BR112022019046A2 (es)
CA (1) CA3170227A1 (es)
CL (1) CL2022002375A1 (es)
IL (1) IL296699A (es)
MX (1) MX2022011542A (es)
PE (1) PE20230344A1 (es)
WO (1) WO2021191800A1 (es)
ZA (1) ZA202209761B (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579543B1 (en) * 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
ITRM20040393A1 (it) 2004-08-03 2004-11-03 Enea Ente Nuove Tec Composizione naturale con proprieta' cicatrizzante, repellente e biocida per il trattamento e la risoluzione delle lesioni esterne.
CN101744794A (zh) * 2008-12-08 2010-06-23 上海四埃美微科技有限公司 天然金丝桃素抗病毒新药
US8846114B1 (en) * 2013-09-05 2014-09-30 Oleavicin, LLC Composition for the treatment of herpes and cold sores
WO2017212422A1 (en) * 2016-06-08 2017-12-14 Novartis Consumer Health Sa Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
BR112019010888A2 (pt) * 2016-11-30 2019-11-12 Lubrizol Advanced Mat Inc uso de um composto, método cosmético, não terapêutico de tratamento e/ou de cuidado da pele, do cabelo, das unhas e/ou das membranas mucosas de um sujeito, e, composto
US10537519B2 (en) * 2017-08-16 2020-01-21 Sci-Chem International Pty Ltd Compositions for treating infections
WO2019046664A1 (en) * 2017-08-30 2019-03-07 Applied Biological Laboratories, Inc. COMPOSITIONS AND METHODS FOR PROTECTING AGENTS FROM PATHOGENS AND IRRITANTS

Also Published As

Publication number Publication date
PE20230344A1 (es) 2023-03-01
KR20220157997A (ko) 2022-11-29
IL296699A (en) 2022-11-01
WO2021191800A1 (en) 2021-09-30
AU2021240472A1 (en) 2022-09-22
EP4125982A1 (en) 2023-02-08
ZA202209761B (en) 2024-02-28
US20210290533A1 (en) 2021-09-23
BR112022019046A2 (pt) 2022-11-01
CN115484969A (zh) 2022-12-16
CL2022002375A1 (es) 2023-04-14
CA3170227A1 (en) 2021-09-30
JP2023519359A (ja) 2023-05-10

Similar Documents

Publication Publication Date Title
HRP20191096T1 (hr) Sastavi koje sadrže bakterijske blautia sojeve za liječenje visceralne hipersenzitivnosti
PE20020237A1 (es) Composicion oral topica
AR052399A1 (es) Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos
NZ718955A (en) Compositions comprising povidone-iodine
BR9507099A (pt) Forma de dosagem método de esterilização composição esterilizante e suplemento alimentar animal compreendendo nitrito acidificado como um agente anti-microbiano
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
EP2046287A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING INFECTIONS
PH12019502240A1 (en) Berberine alkaloid formulations in the prevention and/or treatment of infectious disease
WO2011012855A3 (en) Antibacterial combinations comprising a garlic extract or s -allyl cysteine
MX2022015601A (es) Compuesto para el tratamiento de infecciones coronavirales.
NZ757711A (en) Antimicrobial compounds, compositions, and uses thereof
DE60012610D1 (de) Selektive antibakterielle Zusammensetzungen
MX2022011542A (es) Soluciones antimicrobianas y procedimientos de uso de las mismas en el tratamiento o la prevencion de infecciones.
Rajesvari et al. Lemon grass oil for improvement of oral health
BRPI0607234A2 (pt) método para prevenir e/ou tratar infecções vaginais e vulvares
Nilforoushzadeh et al. Efficacy of adding topical honey-based hydroalcoholic extract Nigella sativa 60% compared to honey alone in patients with cutaneous leishmaniasis receiving intralesional glucantime
IL299751A (en) Preparations and methods for disinfection, treatment and prevention of bacterial infections
WO2015100448A3 (en) Multimodal antimicrobial therapy
CN104523748A (zh) 一种复合碘消毒液及其制备方法和用途
WO2022020353A3 (en) Methods and compositions for treatment and prevention of coronavirus infection
BR112013032567A2 (pt) composição antiparasitária que compreende uma lactona macrocíclica e levamisol e método de tratamento de infestação parasitária
MX2022011596A (es) Compuestos para tratar o prevenir una infeccion por coronaviridae y metodos y usos para evaluar la aparicion de una infeccion por coronaviridae.
Ivantsyk et al. Advantages of the composition and actyvity of a new combined ointment with ethony for treatment of the wound process
WO2004093876A3 (en) Composition containing berberine or a derivative thereof and an antimicrobial agent or an antibiotic agent, and their use for treating oral pathogens and other disorders
MX2021000791A (es) Composicion que contiene beclometasona para la prevencion y el tratamiento de prostatitis y vaginosis bacterianas.